Patents by Inventor John Vrettos

John Vrettos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid Oral Dosage Forms
    Publication number: 20180049987
    Abstract: The present invention provides pharmaceutical compositions suitable for oral delivery of active agent, such as peptides and small molecules, and methods for treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance the bioavailability of therapeutic active agents.
    Type: Application
    Filed: November 3, 2017
    Publication date: February 22, 2018
    Inventors: John Vrettos, Thomas Daggs, Paul Shields, Raymundo Claudio
  • Solid oral dosage forms
    Patent number: 9833411
    Abstract: The present invention provides pharmaceutical compositions suitable for oral delivery of active agent, such as peptides and small molecules, and methods for treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance the bioavailability of therapeutic active agents.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: December 5, 2017
    Assignee: Enteris BioPharma, Inc.
    Inventors: John Vrettos, Thomas Daggs, Paul Shields, Raymundo Claudio
  • Solid Oral Dosage Forms
    Publication number: 20160199303
    Abstract: The present invention provides pharmaceutical compositions suitable for oral delivery of active agent, such as peptides and small molecules, and methods for treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance the bioavailability of therapeutic active agents.
    Type: Application
    Filed: January 12, 2016
    Publication date: July 14, 2016
    Inventors: John Vrettos, Thomas Daggs, Paul Shields, Raymundo Claudio
  • FOMULATION COMPRISING 1 H-QUINAZOLINE-2, 4-DIONE AMPA RECEPTOR ANTAGONISTS, IN THE FORM OF IMMEDIATE RELEASE TABLETS AND PREPARATION THEREOF
    Publication number: 20120263791
    Abstract: The present invention relates to pharmaceutical formulations comprising a 1H-quinazoline-2,4-dione AMPA receptor antagonist. More particularly, the invention relates to immediate release formulations comprising such a compound.
    Type: Application
    Filed: December 21, 2010
    Publication date: October 18, 2012
    Applicant: NOVARTIS AG
    Inventors: Joseph L. Zielinski, John Vrettos, Qin Ji, Subash Patel